Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders LITTLE ELM, Texas – (BW HealthWire) – April 30, 2002 –  Thomas J. Shaw, President and CEO of Retractable Technologies, Inc. (AMEX:RVP – news), a leading maker of safety syringes and blood collection devices, today

Investrend Research Announces Investment Opinion: Retractable Technologies `Strong Buy,’ $11.00 12 Mo Target Issued by Investrend Analyst Justin Canivet, CFA NEW YORK–(BUSINESS WIRE)–April 17, 2002–Investrend analyst Justin Canivet has reiterated a ‘Strong Buy’ and 12 month target of $11.00 on Retractable Technologies (AMEX:RVP). The full report is available at http://www.investrend.com.

Retractable Technologies, Inc. Hires Halliburton Investor Relations to Implement Strategic Financial Communications Program LITTLE ELM, Texas–(BW HealthWire)–April 10, 2002–Retractable Technologies, Inc. (AMEX: RVP – news), a leading manufacturer of safety needle devices, today announced that the company has retained Halliburton Investor Relations (HIR) to develop and implement the company’s strategic

Retractable Technologies, Inc. Announces Significant Revenue Increase for 2001 LITTLE ELM, Texas–(BW HealthWire)–April 3, 2002–Retractable Technologies, Inc. (AMEX:RVP – news; “Retractable’) a leading maker of safety needle devices, today reported record sales for the year ended December 31, 2001. Net revenues for the year ended December 31, 2001 were $16,145,635,

Retractable Technologies, Inc. Receives Contribution From CEO and Spouse Through Royalty Transaction LITTLE ELM, Texas–(BW HealthWire)–Jan. 18, 2002—Retractable Technologies, Inc. (AMEX:RVP – news) a leading maker of safety needle devices, has received a $1 million increase to the shareholders’ equity position by removal of a payable obligation for this same

Britain’s National Health Service Places Retractable Technologies’ Vanishpoint Safety Needle Devices On Supplies List LITTLE ELM, Texas–(BW HealthWire)–Nov. 19, 2001–Retractable Technologies, Inc. (AMEX:RVP), a leading maker of safety needle devices, announced today that Britain’s National Health Service (NHS) Purchasing & Supplies Agency (PASA) has placed Retractable’s VanishPoint(R) line of automated

RETRACTABLE TECHNOLOGIES, INC. ANNOUNCES RECORD REVENUES FOR THE NINE MONTHS AND FUNDING OF $5 MILLION LITTLE ELM, Texas, November 15, 2001— Retractable Technologies, Inc. (AMEX: RVP) (“Retractable”) a leading maker of safety needle devices, today reported record sales for the nine month period ending September 30, 2001. In addition, the

Joint Purchasing Corp. to Distribute Retractable Technologies’ VanishPoint Safety Syringes NEW YORK–(BW HealthWire)–Oct. 25, 2001–Joint Purchasing Corporation (JPC), a non-profit health services organization based in New York, announced today that the VanishPoint® automated retraction safety syringe is now available through its wide-reaching distribution network. Through a supply agreement between JPC

Retractable Technologies’ VanishPoint Safety Needle Devices Approved for Sale in Japan LITTLE ELM, Texas–(BW HealthWire)–Oct. 23, 2001–Retractable Technologies, Inc. (“Retractable”) (AMEX:RVP – news) a leading maker of safety needle products, announced today that it had received approval from the Japanese Ministry of Health, Welfare, and Labor to begin marketing its

Investrend Announces Investment Opinion: Retractable Technologies Strong Buy and $12.60 Target Initiated by Investrend Research Analyst Sherry Grisewood, CFA NEW YORK–(BUSINESS WIRE)–Sept. 24, 2001–Investrend Research (http://www.investrend.com) analyst Sherry Grisewood, CFA, has initiated coverage of Retractable Technologies, Inc. (AMEX:RVP – news), with a Strong Buy recommendation and one year price target